Matrix extracellular phosphoglycoprotein inhibits phosphate transport

Area of Science:

• Endocrinology
• Nephrology
• Gastroenterology

Background:

• Phosphate homeostasis is regulated by humoral factors called phosphatonins.
• The roles of phosphatonins in kidney and gastrointestinal phosphate handling are not fully understood.
• Matrix extracellular phosphoglycoprotein (MEPE) is a candidate phosphatonin that promotes phosphaturia, but its effect on intestinal phosphate absorption is unknown.

Purpose of the Study:

• To investigate the effect of MEPE on intestinal phosphate absorption.
• To determine the impact of MEPE on renal phosphate handling and transporter expression.
• To elucidate MEPE's role in phosphate homeostasis.

Main Methods:

• In situ intestinal loop technique in rats to assess jejunal and duodenal phosphate absorption.
• Measurement of urinary phosphate excretion.
• Western blotting and immunohistochemistry to evaluate renal sodium-phosphate co-transporter NaPi-IIa protein levels.

Main Results:

• MEPE infusion significantly inhibited phosphate absorption in the jejunum but not the duodenum.
• MEPE administration led to a reduction in NaPi-IIa protein levels in proximal renal tubules.
• These effects occurred without altering circulating levels of parathyroid hormone, 1,25-dihydroxyvitamin D(3), or fibroblast growth factor 23.

Conclusions:

• MEPE acts as a phosphatonin influencing phosphate absorption in the jejunum.
• MEPE reduces renal phosphate reabsorption by decreasing NaPi-IIa expression.
• MEPE plays a role in regulating phosphate homeostasis in both the kidney and the gastrointestinal tract.